Skip to main content
OpenTrials

Clinical trial condition

Neoplasms by Histologic Type

Explore clinical trials studying Neoplasms by Histologic Type. Study availability and eligibility vary by location and protocol.

30,146 public trials 6,477 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms by Histologic Type trial results

Recruiting

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

NCT06106945

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Boston, Massachusetts, United States
View all 43 locations
View Trial Details
Recruiting

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

NCT05977673

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia Alessandria, IT, Italy
  • Divisione di Oncologia e dei Tumori immuto-correlati, Centro Di Riferimento Oncologico Di Aviano Aviano, Italy
  • Istituto di Ematologia L. e A. Seràgnoli, AOU Policlinico S. Orsola-Malpighi Bologna, Italy
  • SC Ematologia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia Brescia, Italy
View Trial Details
Recruiting

EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma

NCT06556563

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
View all 102 locations
View Trial Details
Recruiting

Study on Plasmablastic Lymphoma Patients

NCT06781359

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • IRCCS Centro di Riferimento Oncologico di Aviano, Divisione di Oncologia e dei Tumori immuno-correlati Aviano, PN, Italy
  • Ospedale C.e G. Mazzoni, U.O.C. di Ematologia Ascoli Piceno, Italy
  • ASST Spedali Civili di Brescia, Ematologia Brescia, Italy
  • A.O. S. Croce e Carle, S.C. di Ematologia e Trapianto di Midollo Osseo Cuneo, Italy
View all 23 locations
View Trial Details
Recruiting

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

NCT07630545

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +19 more
Locations
  • The Royal Adelaide Hospital Adelaide, Australia
  • Doherty Clinical Trials Melbourne, Australia
  • Monash Health, Kingston Centre Melbourne, Australia
  • Centre Hospitalier Universitaire de Lille, Institut Cœur Poumon Lille, France
View all 18 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

NCT07221500

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Institute Denver, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 37 locations
View Trial Details
Recruiting

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

NCT05361720

Conditions
Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +18 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT02734537

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 679 locations
View Trial Details

Related conditions